Tags Posts tagged with "legal marijuana"

legal marijuana


The legal marijuana industry is the fastest growing industry in the world and investors are frequently trying to learn how to invest in marijuana stocks. Over the last two years, the industry has exploded and now medical cannabis is legal in Australia, Germany, Canada, Uruguay, Colombia, and the Netherlands.

The rapid growth of the legal marijuana industry has led to a surge in the number of opportunities and only here, can you access the best information and learn how to invest in marijuana stocks and capitalize on this incredible industry.

The legal marijuana industry offers immense upside but investors still need to be selective with their investments. This new growth industry is exciting but investors need to educate themselves and learn how to invest in marijuana stocks before doing so.

How Do I Invest in Marijuana Stocks?

While it may sound complicated, it is actually very easy to open a brokerage account began buying and selling stock. The easiest and cheapest way to start investing is by opening an online brokerage account. Here are some of the most common online brokerages:

  • E-trade: www.etrade.com
  • Interactive Brokers- www.InteractiveBrokers.com
  • Merrill Edge – www.MerrillEdge.com
  • Scottrade- www.Scottrade.com/Brokerage

Access the best information for free today by signing up for the MarijuanaStocks.com newsletter.



1 16943

“Wait did I read that correctly?” you’re probably asking yourself, right? Mr. Sessions has seemingly been the thorn in the side of the legal marijuana movement and he’s been a topic of great debate for days now. But there may be some shining light ahead to put a bit more ease to those looking at this industry and in their favor. Yes, worries about this “great shift” in federal enforcement in states where recreational legalization has been granted may be able to breathe a little easier right now.

There’s been an immense amount of angst and paranoia with regard to what some have understood as a government crackdown on recreational use. U.S. Attorney General Jeff Sessions has had private discussions with a few Republican senators saying that he doesn’t plan to stray away from the Obama-placed policy of granting states the ability to enact their own marijuana laws for their residents.

Sessions has been a strong force to be reckoned with after he ordered a review of the “hands-off” policy that President Barack Obama previously had. But apparently Mr. Sessions has had a bit of a change of heart and in private conversations, has assured senators before he was confirmed that he didn’t have too much consideration about drastically changing the enforcement laws; even though he’s not a fan of the drug’s use.

Here are a few quotes from these informed senators:

“Nothing at this point has changed,” said Sen. Cory Gardner (R-Colo.)

“He told me he would have some respect for states’ right on these things. And so I’ll be very unhappy if the federal government decides to go into Colorado and Washington and all of these places. And that’s not the [what] my interpretation of my conversation with him was. That this wasn’t his intention.”

-Sen. Rand Paul (R-Ky)

“We respectfully request that you uphold DOJ’s existing policy regarding states that have implemented strong and effective regulations for recreational use. It is critical that states continue to implement these laws.”

-Sens. Elizabeth Warren (D-Mass.) & Lisa Murkowski (R-Alaska)

“Do they really respect states’ rights? Then you should respect all of them, not just pick and choose the ones that you want to support or not. Many states have gone not only the path of Nevada of recreational marijuana but medical marijuana. How can you pick or choose one or another?”

-Sen Catherine Cortez Masto (D-Nevada)

A group of bipartisan senators also had submitted a letter on Thursday that pushed for Sessions to keep the Obama-era policy intact in order to let states decide on how to implement recreational marijuana laws. Sen. Warren and Sen. Murkowski lead the effort; both of who are from states who’s already put legalized marijuana laws in place.

To date, 8 states and Washington, D.C. have laws in place that legalize marijuana for recreational use. Most senators who signed on the letter are from those states with Murkowski being the only Republican. The others include:

Sen. Patty Murray of Washington
Sen. Ron Wyden of Oregon
Sen. Jeff Merkley of Oregon
Sen. Maria Cantwell of Washington
Sen. Ed Markey of Massachusetts
Sen. Brian Schatz of Hawaii
Sen. Catherine Cortez Masto of Nevada
Sen. Cory Booker of New Jersey
Sen. Michael Bennet of Colorado

The concern isn’t just among senators from those states but is an issue among many conservatives who are nervous about the GOP being selective about allowing the rights of states to supersede federal law.

“We’re concerned about some of the language that we’re hearing. And I think that conservatives who are for states’ rights ought to believe in states’ rights. I’m going to continue to advocate that the states should be left alone,” Paul said.

Sen. Gardner was even more direct with the opinion on Sessions’ comments, “He was talking about if there’s cartels involved in illegal operations, they’re going to crack down on that. That’s what everybody’s saying. I still haven’t heard Jeff Sessions say that. We obviously want to make sure we’re clear on what they’ve said.”

Despite the shake-up that Sessions almost single-handedly ignited with his comments about “not being a fan of expanded use of marijuana,” or how despite him being open to states passing laws that they choose, he made it a point to say, “it does remain a violation of federal law to distribute marijuana throughout any place in the United States, whether a state legalizes it or not,” senators like Murkowski seem unshaken. In fact Murkowski said that she wasn’t alarmed and is simply monitoring the DOJ closely, “It’s probably a little premature to try to predict what may or may not be coming out of the administration on this, so I think we just need to sit back and see.”

4 10702

By Jason Spatafora @WolfofWeedSt

“I fear the Greeks, even those bearing gifts.”- Virgil

The DEA’s recent cannabis research expansion is a Harry Houdini inspired smoke show of misdirection all to set up the next trick; there I said it. While some view it as a positive first step, I tend to think it served a very deliberate function. Optically it played directly into expected vitriolic fallout from advocates, activists and media touts, all of which lined up to ignite their “DEA should reschedule cannabis” torches. In a “perfect world” scenario these people aren’t wrong, cannabis isn’t Heroin’s equal & 1+1=2, but just as fire cannot exist in a vacuum, neither can a rational cannabis debate. And while everyone on the side of reason is shouting in unison about rescheduling they failed to see that they might have just had their pockets picked. DEA’s policy statement that everyone seemed to ignore there are 33 words that have the potential to create the legal framework for the monopolization of Cannabis by means of an exclusionary application process.

Prologue – August 10th, 2016

Russ Baer, a staff coordinator for the Drug Enforcement Administration (DEA) media affairs wing gave a response to Steven Nelson of USNEWS.com via email. Nelson later shared a screen grab of the email via tweet. The statement made to him from this Drug Enforcement Administration staff coordinator read:

“Tomorrow morning (August 11th, 2016) the Drug Enforcement Administration will be making some important announcement regarding Marijuana related topics that will be published in the Federal Register. Because of your interest and/or prior engagement with the DEA on this subject, the DEA office of National Media Affairs is reaching out to you regarding these anticipated announcements.”

Over the next 24 hours social media was a blaze, with many people within the industry uncovering the fact that Rescheduling wouldn’t happen and that the DEA response would have to do with research. As expected, the incendiary scheduling of cannabis debate raged on into the following day.

August 11th, 2016

As expected, the Drug Enforcement Administration disappointed the advocates and activists of medical marijuana by not removing or rescheduling marijuana from its class 1 controlled substance status. Yet the DEA, in all of its benevolence, offered a consolation prize of sorts, by “deciding” to expand the study of Medical Marijuana for researchers, Universities & drug companies outside of the confines of a single federally legal facility. The facility, to refresh your memory is located at the University of Mississippi, (ranked 164th in Bio Sciences) and had up to this point been the sole research monopoly on legally grown marijuana, courtesy of the NIDA (National Institute on Drug Abuse).

DEA’s Misdirection Strategy

Over the next few days it seemed that every headline following the DEA’s deliberation was about the archaic rescheduling system & how cannabis is safer statistically than opiates that are schedule 2. Some media outlets went as far as to paint a “glass half full” picture. The LA Times for example did a piece titled “DEA ends its monopoly on marijuana growing for medical research.” The social reaction from cannabis enthusiasts, advocates and potrepreneurs from Main Street to Wall Street was as expected with everyone chiming in on social media to wag their fingers at the DEA. Representative Barbara Lee, a congresswoman from Oakland California stating via tweet “Politicians aren’t doctors or scientists. Marijuana research prohibitions are outdated, unscientific, & dangerous for those who need #MMJ.” As expected the rhetoric from the cannabis side was “The DEA is bad, the War on Drugs is a complete failure, Big Pharma is to blame,” so on and so forth.


The people aren’t wrong on many of these points. The War in Drugs is a failure when considering addiction has been plateauing since its 1970 inception and US drug control spending is up 2000%, which to date stands at $1.5 trillion dollars. We can go on and on as to where that money went, what industries it created (prison industrial complex), the people it disproportionately targeted (minorities), but that’s a whole other article or book for that matter. Big Pharma however does have its trillion dollars hands in this story, but more on that later as I’ve digressed.

Not to go back and pick on the LA Times click-bate headline of “DEA ends its monopoly on marijuana growing for medical research,” but did it really end the monopoly? Let’s evaluate the idea. Yes, a monopoly is defined as “the exclusive possession or control of the supply or trade in a commodity or service.” The University of Mississippi was in fact in exclusive possession of the NIDA edict to legally grow marijuana and study it. On the surface the Monopoly has ended, but the reality is that we are just switching out the term Monopoly for an Oligarchy. Is an oligarchy any different than a monopoly in the sense that it’s just a smaller group carving out the biggest slices for themselves, eliminating competition by means of out maneuvering or outspending their opponent in an effort to influence policy such as this? Consider that the biggest lobby against the cannabis Industry is the pharmaceutical industry, yet they’re simultaneously studying cannabis for the purpose of synthesizing its many chemical compounds to create their high margin drugs.

Currently, their high margin bread and butter are the opioids for pain management such as OxyContin, Percocet and their generic versions of each. The drug companies are experts at isolating molecules from nature to create drugs that cost pennies to manufactures. In a zero sum game, cannabis is a direct threat to pharma companies, by snatching billions in profit and simultaneously causing billions in losses. Anti-cannabis lobbies would also be at risk as the pharmaceutical giants that feed them down on K Street would lose out on easy paydays. These anti-Marijuana lobbyists provide a micro look at the systemic problems within American politics illustrating how/why elected officials in Congress consistently vote against the interests of their collective constituency and bring forth carefully crafted bills or amendments like this one.

On the DEA’s policy statement and legal considerations section, under, legal applicable considerations it states.

“Second, as with any application submitted pursuant to section 823(a), in determining whether the proposed registrationwould be consistent with the public interest, among the factorsto be considered are whether the applicant has previous experience handling controlled substances in a lawful manner and whether the applicant has engaged in illegal activity involving controlled substances. In this context, illegal activity includes any activity in violation of the CSA (regardless of whether such activity is permissible under State law) as well as activity in violation of State or local law. While past illegal conduct involving controlled substances does not automatically disqualify an applicant, it may weigh heavily against granting the registration.”

Translation, grow marijuana even in a state where it’s legal and you are going to have a hard time becoming a manufacturer or researcher for the DEA’s new policy, thus excluding tier one cultivators in practice and likely creating a perpetual home for cannabis on the scheduling list. Prohibition’s end could very well be right around the corner, but the fear is in the form of legal medical marijuana at a Walgreens near you. I asked the DEA’s Russ Baer directly if the inserted language above in bold would be a non-starter for current cultivators wanting to become manufacturers as they are in clear Violation of CSA? In a written statement to Marijuana Stocks the DEA’s official response was:

“DEA is serious about facilitating marijuana research and that there is a lawful pathway for doing so. This DEA decision will facilitate increased research involving marijuana, within the framework of the law and U.S. treaty obligations, to enhance the drug’s supply available to researchers. The goal of this historic and monumental policy shift is to increase the amount and variety of marijuana available to researchers and make it easier for researchers to obtain marijuana as compared to current system under which marijuana must be obtained from NIDA. Growers must become registered with DEA, following the submission of an application, which DEA will evaluate in accordance with the CSA. Registered growers will need to comply with all CSA regulatory requirements, such as quotas, record keeping, order forms, and maintenance of control against diversion. Marijuana produced under this proposal may only be supplied to DEA-registered manufacturers and researchers, and only for purposes authorized by the CSA.

All potential new drugs, including drug products made from marijuana, are subject to the rigors of the drug approval process mandated by the Federal Food, Drug and Cosmetic Act (FDCA). This drug approval process requires that before a new drug is allowed to enter the U.S. market, it must be demonstrated through sound clinical trials to be both safe and effective for its intended uses,” stated Russ Baer of the Drug Enforcement Agency.

When asked if the inserted language also creates an unfair advantage for Pharma companies the response from the Drug Enforcement Administration circled back to the CSA (Controlled Substance Act) stating that the “DEA has adopted a new policy, consistent with the CSA and U.S. treaty obligations, under which additional entities may become registered with DEA to grow and distribute marijuana for research purposes. DEA will evaluate each application it receives to determine whether adding such applicant to the list of registered growers is necessary to provide an adequate and uninterrupted supply of marijuana to researchers in the U.S. In addition, applicants must demonstrate their ability to safely secure the drugs to prevent diversion, while abiding by the approved research protocol.”

The Controlled Substance Act

Everything points back to the Controlled Substance Act, a bill that was introduced into the Congress by Harley Staggers and took less than 6 weeks to get passed by the Senate and signed into law by President Richard M. Nixon. The signing of this document not only created the “War on Drugs,” but put an enforcement agency (DEA) in charge of Cannabis scheduling, circumventing the FDA in a move that creates an inter-agency firewall of sorts. The DEA’s position on why the FDA, who already regulates pharmaceutical drugs, isn’t in charge of marijuana rescheduling was point blank, “The Controlled Substances Act provides a mechanism for substances to be controlled (added to or transferred between schedules) or decontrolled (removed from control). The CSA provides roles for DEA and the FDA. Proceedings to add, delete, or change the schedule of a drug or other substance may be initiated by DEA, HHS, or by petition from any interested party. Once initiated, the process involves a deliberate and collaborative interagency exchange.”


In Laymen’s terms CSA effectively says “DEA you’re in charge of this, FDA you’re in charge of that.” Unfortunately, Marijuana will never be completely removed from the scheduling list unless there is a major political overhaul in every branch of government, if and only if elected officials stop letting lobbies pour honey in their ears and money into campaigns. The reality from my perspective is that the DEA is a scapegoat, the perfect Boogey Man, simply because their job is to follow orders. They are soldiers in a sense, adhering to the guidelines of the Controlled Substance Act (CSA), a legal document crafted by a congress, molded in the image of benefactors, used to fuel a fake war and create cottage industries.

The DEA knows marijuana is safer than Oxy and that’s not speculation that’s a direct quote. They don’t want to go after the mother transporting medication to her sick child because they’re suffering from seizures. They want the dangerous individuals like El Chapo or the pill mills slinging Oxy off the streets. They have no interest in going after all cultivators following state law to the letter. Are there exceptions, of course! Does it make these comments directly from them any less true? No.
DEA’s direct position on which drug is more dangerous from a consumption standpoint as it relates to Cannabis vs OxyContin? “There were more than 47,000 drug overdose deaths in 2014, or approximately 129 per day, more than half (61 percent) of which involved either a prescription opioid or heroin. Marijuana meets the statuary criteria of a Scheduled I controlled substance, and has been determined to have a high abuse potential with no currently accepted medical use. Schedule I includes some substances that are exceptionally dangerous (including heroin and LSD) and some that are less dangerous (including marijuana, which is less dangerous than some substances in other schedules).” When asked point blank, what’s more dangerous Oxy or Marijuana DEA says “Oxy.”

Robert Capecchi, Director of Federal Lobbying at the Marijuana Policy views medical marijuana legalization as a means to an opioid end as well as fiscal no brainer with far reaching benefits.

“Ending marijuana prohibition will allow licensed businesses to cultivate, distribute, and sell marijuana to adults. Unlike the criminal market, a legal and regulated market means products are pure, tested and labeled, sales are taxed, and business disputes are resolved in the courts, not with violence. Additionally, there is promising evidence to suggest that legal access to medical marijuana reduces the rates of opioid overdoses and the reliance on prescription pain killers.”

Foregone Conclusion?

Prohibition’s end could very well be right around the corner, but would we want it in the form of legal medical marijuana at a Walgreens near you? August 11th’s ruling was either one of many dominos in the quest for the monopolization of cannabis or just a pessimistic idea based off of history repeating itself. Regardless of which reality we are presently in, it doesn’t hurt to try and connect the dots, but if I can leave you with one last thing it’s the number 6630507. In case you’re wondering that’s the United States patent # they filed for cannabis in 2003 citing “multiple therapeutic uses.” I can only postulate why they did that….


Jason Spatafora

Drug War

0 2956

MassRoots Releases Fall 2016 Product Pipeline, to Host Facebook Live Q&A from Elevate Cannabis Technology Conference

DENVER, Sept. 20, 2016 /PRNewswire/ — MassRoots, Inc. (MSRT), one of the largest and fastest growing technology platforms for the cannabis industry, is pleased to release its product roadmap for fall 2016. Through its community-driven reviews, MassRoots aims to connect consumers with the products that will best treat their ailments at their local dispensary.

Product Reviews
The MassRoots App will soon enable users to leave reviews of particular products and tag the dispensary from which they were purchased. In future iterations, users will be able to rate the product based on a variety of factors, i.e. back pain relief.

Live Menu Pricing
Through MassRoots’ partnership with Headset, dispensaries will soon be able to display live inventory and pricing information on their MassRoots profile, regardless of which point-of-sale system they use. This will enable users to see how much a particular product costs at their local dispensary, providing more value to both MassRoots’ users and clients.

Improved Business Portal
Through MassRoots’ partnership with Headset and integrations with Flowhub, we intend to display the most useful information for dispensaries in easy-to-use, actionable formats and enable dispensaries to target advertising based on that information.

“When a new state passes a medical or recreational cannabis law, we are able to start registering users and businesses in that state with minimal marginal cost. Because MassRoots is not involved in the production or sale of cannabis, we do not have to build outgrow operations, open retail stores, or have a significant physical presence in the state in order to generate revenue,” stated MassRoots CEO Isaac Dietrich. “At the same time, MassRoots’ financial model is not tied to the success of a particular location or brand – we believe we will have a significant percentage of all dispensaries and brands on our platform, making MassRoots a play on the industry as a whole.”

MassRoots CEO Isaac Dietrich will be speaking on the Data in Cannabis panel at the Elevate Startup Technology Conference this afternoon and will be hosting a Facebook Live Q&A from the event today, September 20, 2016, at 2:00pm EDT on MassRoots’ Facebook Page.

About MassRoots
MassRoots is one of the largest and most active technology platforms for cannabis consumers, businesses and activists with over 900,000 registered users. It is proud to be affiliated with the leading organizations in the cannabis industry, including the ArcView Group and National Cannabis Industry Association. MassRoots has been covered by Fox Business, CNBC, Fortune, Denver Post, and The Financial Times. For more information, please visit MassRoots.com/Investors.

Forward-looking Statements
Certain matters discussed in this announcement contain statements, estimates and projections about the growth of MassRoots’ business, potential partnerships, new features, and related business strategy. Such statements, estimates and projections may constitute forward-looking statements within the meaning of the federal securities laws. Factors or events that could cause our actual results to differ may emerge from time to time. MassRoots undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. The recipient of this information is cautioned not to place undue reliance on forward-looking statements.

0 1170
You may have heard the common phrase “As goes New York, so goes the nation.” As one of the financial capitals of the world, New York has a lot of influence. This may include marijuana laws; therefore, the intense cutthroat cannabis industry that New York has created might just spread throughout the country. Unfortunately, that would make marijuana too expensive to be bought by a regular patient. In January, New York launched its medical marijuana program. However, there have been many concerns that the strict laws and such have made it too difficult for most people to get their hands on the medicine. A newer report from the Drug Policy Alliance (DPA) indicated that most of those that are in the program have too many obstacles for anyone to even enter.
Take this for instance: the report states that the strict nature of the Compassionate Care program, which does not allow home growth or inhaled cannabis, has made marijuana products so expensive that almost eighty percent of those approved to use medical marijuana cannot afford it. In order to make things even worse, the DPA continues to suggest that most patients are set to fail even before they set out to hunt medical marijuana because less than one percent of doctors in the state have the opportunity to recommend marijuana to anyone with “severe, debilitating or life-threatening” conditions.
“More than half of patients and caregivers surveyed had not yet found a doctor to certify them, and among those, 3 out of 5 have been waiting for 3 to 4 months to locate a registered physician,” the report states.
However, even if a patient was lucky enough to find a doctor that would be able to recommend them cannabis, and the patient can afford it, it is still difficult to obtain medical marijuana.


0 1539

Throughout the last few years, marijuana has become very popular among the public. In fact, more than half the nation now supports legalization. That means more and more people are becoming open to the idea of marijuana, and furthermore, more and more people are using the drug. This does not exclude celebrities. Let’s take a look at some famous potheads:

1. Miley Cyrus

Miley Cyrus used to be the queen of the Disney World with her run as Hannah Montana. People were unsure about this during the beginning of her transformation, but it became clearer. Eventually, she just flat out told Rolling Stone that “weed is the best drug on Earth.” Then, if that wasn’t clear enough, she began smoking on stage during one of her concerts. Yup, she’s a stoner.

2. Rihanna

This should come off as a surprise to anyone. There are pictures all over the internet of Rihanna smoking weed. There is even one of her rolling a blunt on her security guard’s head while mounting his shoulders. Seriously. Yup, she’s a pothead.

3. Morgan Freeman

Morgan Freeman, the man with the voice of voices, admitted to having smoked weed and drinking a lot in the past. He gave it up like most celebrities end up doing… Well, almost all of it. He stated during an interview that “I’ll never give up the ganja,” calling it “God’s own weed.”

4. James Franco

This one should not come off as a surprise to many people. However, he says that he gave up smoking weed in 2008. This is actually right before he made the movie Pineapple Express, where he played a drug dealer. He said “I used to smoke weed, but I haven’t done it in a long time. Everybody, even now, thinks, ‘That guy is stoned.’ It’s just the way I talk because I don’t smoke weed. Somehow, there’s something about me, the way I talk; that implies that I’m on drugs.”

5. Oprah

“You get a blunt, you get a blunt, you get a blunt!” Here is the big shocker. Oprah admits that she was smoking weed very actively back in the day, but decided to stop smoking in 1982. The most famous celebrity admitted this on Watch What Happens Live, but does not associate herself with the drug anymore. Sure, Oprah, sure.

0 4228

CHEYENNE, Wyo., April. 7, 2016 /PRNewswire/ — FBEC Worldwide, Inc. (FBEC) a  lifestyle brand company with a focus on Healthy Hemp™ & CBD infused consumer products, is pleased to announce it has successfully acquired & registered the trademark “Healthy Hemp™”. FBEC’s Healthy Hemp™ is trademarked for class 05 Dietary Beverage Supplements for Therapeutic Purposes, for class 030 Herbal Food Beverages and for class 034 Oral Vaporizers for smoking purposes.

CEO Jeffrey Greene stated, “Healthy Food is an incredibly fast growing $1 Trillion market. WolfShot™, our leading Healthy Hemp™ product, has been designed to be the first Energy Shot loaded with therapeutic hemp juice to meet the strong demand for a healthy solution in the currently tarnished & beleaguered Energy Shot market. Now we can finally have a dependable healthy solution that is good for everyone, and that’s no bull…pun intended. “

“Using my contacts and resources, one of my main goals is to court relationships with retail stores I feel we are a perfect fit for, such as, Whole Foods Market, Inc. (WFM), Albertsons, The Fresh Market & Trader Joe’s. It’s worth noting that all the retailers I mentioned  already carry some products such as, hemp seed, hemp milk, hemp oil or hemp powder,” said Mr. Greene.

About FBEC Worldwide, Inc.

FBEC Worldwide, Inc. is a lifestyle Brand Company with a focus on Healthy Hemp™ & CBD infused consumer products, both domestic and abroad. We are committed to increasing our market size and scope through the optics of creative marketing and most importantly customer satisfaction. Our growth strategies focus on a number of major initiatives, including unique branding opportunities that will be targeted at key demographic groups and to develop strong community and distributor relationships.

FBEC Worldwide is currently developing and building Healthy Hemp™ & CBD infused consumer products, focused on strong rates of growth within key fundamental consumer groups. Our company is dedicated to becoming the lead developer of name brand hemp & CBD infused consumer products.

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The Company’s operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company’s periodic filings with the U.S. Securities and Exchange Commission.

Investor Relations Contact:

Joe Sirianni
MIDAM Ventures LLC
(305) 707-7018

0 2114


Looking for a safe spot in the legal marijuana market in Colorado, black market cannabis merchants are hiding marijuana cultivation throughout legal cannabis farms and warehouses. Afterward, they secretly send it off somewhere else and end up making million of dollars under the table, law enforcement officials and court records reveal.

In one case, the proprietor of a skydiving business packed many pounds of Colorado pot into his planes and flew the weed to Minnesota, where dealers supposedly sold it for a large number of dollars in real money. In another, a Denver man was accused of sending more than 100 pot-filled FedEx bundles to Buffalo, New York, where street pharmacists separated the shipment. Twenty other drug dealers, numerous from Cuba, were blamed for migrating to Colorado to develop weed that they sent to Florida, where it can get more than twofold the cost in a lawful Colorado shop.

These cases and others affirm a longstanding fear from cannabis antagonists that the state’s greatly watched experiment in legal marijuana would welcome more unlawful trafficking to different states where the plant is still entirely prohibited. One source is Colorado inhabitants or sightseers who purchase retail pot and take it out of state. In any case, more of a worry to officials are huge scale traffickers who move to Colorado particularly to develop the drug and send it to more profitable markets.

The pattern likewise reinforces the contention of neighboring Nebraska and Oklahoma, which documented a claim in late 2014 trying to proclaim Colorado’s marijuana legalization unlawful, contending that the move sent a tide of illegal weed over their fringes. The Obama organization a month ago asked the Supreme Court to dismiss the suit, saying that the trafficking was not Colorado’s issue.

Nobody knows precisely the amount of cannabis that leaves Colorado. At the point when illicit shipments are grabbed, it’s regularly difficult to demonstrate where the cannabis was developed. In any case, court records and meetings with law authorization authorities show that dealers are looking for shelter in Colorado’s prospering marijuana industry.

    1 1606

    FBEC Worldwide, Inc. (FBEC), a beverage company with intellectual property formulas and marketing capability for the production and distribution of proprietary beverages, is pleased to announce Damn Air Freshener (DAF) is taking delivery of their initial purchase order of WolfShot™ today. The Company announced DAF as their first national distributor last week.

    WolfShot™ will be distributed to over 500 stores in Texas, Louisiana, New York, Rhode Island, Maryland, and Washington. Some of the store locations to carry the product will be Exxon, Citgo, Chevron, Phillips, Race Way, Shell, Texaco, Valero, Conoco, Gulf, and numerous other local smoke shops and convenient stores.

    DAF was strategically selected to be the Company’s first national distributor because they are headquartered in Houston, Texas. The Company’s co-packer, Neumatter Methods, is also located in Houston. This will prove to be cost effective and even cut back on overall production costs. DAF has a strong presence in the South with a focus on head shops, smoke shops, convenient stores, and gas stations. These establishments fall right in line with the Company’s sales strategy and target retail locations.

    About FBEC Worldwide, Inc.

    FBEC Worldwide is an innovative beverage company dedicated to offering proprietary products focused towards significant target markets, both domestic and abroad. We are committed to increasing our market size and scope through the optics of creative marketing and most importantly customer satisfaction. Our growth strategies will focus on a number of major initiatives including, unique branding opportunities that will be targeted at key demographic groups, and to develop strong community and distributor relationships.

    As we look ahead, FBEC Worldwide will develop and build name brands focused on strong rates of growth within key fundamental consumer groups. Our company is dedicated to becoming a leading developer of name brand beverage alternatives geared specifically towards large, significantly important demographics within major markets.

    Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company’s progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management’s opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The Company’s operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company’s periodic filings with the U.S. Securities and Exchange Commission.


    Joe Sirianni
    MIDAM Ventures LLC
    (305) 707-7018

    0 5386

    If you take a glance at the markets for marijuana and related industries, prices have seen a rebound where many “played out” stocks have received a breath of fresh air…along with their long-term investors. Many are even calling this the rebirth of pot stocks as a whole and for new companies coming into the space, this along with tighter regulations to protect investors could be significant catalysts for the market to continue to grow, literally.

    But the fact of the matter still remains that without the actual plant itself, users, retailers, and alchemists would have nothing. Today’s economic boom within legal marijuana has ignited a firestorm of interest from some of the most unlikely proponents of marijuana’s success. Biologists and engineers have experimented with digital sensors, lighting arrays, software programs and ventilators to self-contained systems with the lowest energy costs and highest crop yields.

    Being that marijuana needs a precise balance of light, moisture and water to thrive it is a very finicky crop but new technologies outside of the typical outdoor grow or even traditional green house grow have begun to come about. As the U.S. and more countries ease up their policies on both medical and recreational marijuana, the race is on by companies working to become the industry leaders in data-mining software, lamps with efficiency accessories and adequate irrigation systems.

    These tools will ultimately benefit more than marijuana growers alone. We’re talking things like industrial food producers and even the hemp growers could adapt the same technologies to cut energy costs and boost their yields. Operators of large buildings could use the systems to lower their electricity use as well. By compartmentalizing these units, growers have been able to streamline operations, magnify growing conditions and yield more consistent crops multiple times throughout the year.

    Cannabis is spurring on an ag-tech revolution. This is a boom born entirely out of ending repressive laws. The market is already there, it’s just moving from the shadows into the light. That’s why you’re seeing this incredible growth and why so many people see it as a once-in-a-lifetime [business] opportunity.”

    -Troy Dayton, CEO of ArcView Group.

    Technology advancements in the marijuana industry focus mainly on interior cooling, air circulation, and lighting, which together take up about 70% of the overall cost to actually grow a single gram of weed; this is according to some projections. Using water more efficiently, take up less stress on the electrical grid while providing greater yields is a very realistic advantage of these more controlled “grow box” style units. Others are even being designed to automate the real-time response to changes in variables like moisture, sunlight and temperature, in order for the cannabis to grow in an optimal environment. Technologies also collect a wealth of data, which gives growers an upper hand when it comes to adjusting their growing environments to find the best conditions for multiple varieties.

    Timing may not be any better than right now to start digging into this industry. The space is drawing interest from the mainstream believe it or not. A subsidiary of Scotts Miracle-Gro Co., Hawthorne Gardening Co. in April, purchased General Hydroponics Inc. and Bio-Organic Solutions Inc. They make liquid nutrients for indoor marijuana cultivation and this is just one example of the types of investments these “blue chip” companies are making in order to get a foot in the door when it comes to the new kinds of growing environments being created.

    No longer are harvests limited to a few times a year. These grow boxes can produce several FULL harvests per year and when it comes to out put meeting demand this is one of the most important aspects of a successful grow. Furthermore, with the industry attracting a new breed of entrepreneurs who may have never even touched marijuana before, grow box manufacturers also need to consider ease of use; Can it be “plug and play”?

    U.S. cannabis sales alone reached $2.7 billion in 2014, a $1.1 billion gain over 2013. Now think about this for a moment, Colorado marijuana sales alone for the first 8 months of 2015 totaled nearly $700M (almost 30% of the total U.S. sales for 2014 and remember…that’s just Colorado). The market continues to grow and so has the increasing demand for a consistent, quality product that as of recent has been found to be a byproduct of indoor grow box cultivation methods. It would stand to reason that just like the picks and shovels of the gold rush, these lights, water units, and especially the cultivation boxes will become an industry all their own.

    Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

    We are your #1 source for all things Marijuana Stocks, Subscribe Below!

    Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
    Ad Placements